{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:28:51Z","timestamp":1786649331743,"version":"build-2736575974"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Venous thromboembolism (VTE) has been a subject of great interest of late. Since Rudolph Virchow described the famous Virchow's triad in 1856, there have been rapid strides in the understanding of the pathogenesis and factors responsible for it. Discovery of various thrombophilic factors, both primary and acquired, in the last 40 years has revolutionized prognostication and management of this potentially life-threatening condition due to its associated complication of pulmonary thromboembolism. Detailed genetic mapping and linkage analyses have been underlining the fact that VTE is a multifactorial disorder and a complex one. There are many gene-gene and gene-environment interactions that alter and magnify the clinical picture in this disorder. Point in case is pregnancy, where the risk of VTE is 100-150 times increased in the presence of Factor V Leiden, prothrombin mutation (Prothrombin 20210A) and antithrombin deficiency. Risk of VTE associated with long-haul air flight has now been well recognized. Thrombotic events associated with antiphospholipid syndrome (APS) are 70% venous and 30% arterial. Deep venous thrombosis and pulmonary embolism are the most common venous events, though unusual cases of catastrophes due to central vein thrombosis like renal vein thrombosis and Budd-Chiari syndrome (catastrophic APS) may occur.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/0022-3859.48442","type":"journal-article","created":{"date-parts":[[2009,2,26]],"date-time":"2009-02-26T23:35:16Z","timestamp":1235691316000},"page":"55-64","source":"Crossref","is-referenced-by-count":6,"title":["Venous thromboembolism"],"prefix":"10.4103","volume":"55","author":[{"given":"TK","family":"Dutta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Venugopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-14-20240205","first-page":"171","article-title":"Risk factors for venous thrombosis: Prevalence, risk and interaction","volume":"34","author":"Rosendaal","year":"1997","journal-title":"Semin Hematol"},{"key":"R3-14-20240205","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0889-8588(05)70140-4","article-title":"Risk factors for venous thromboembolism following prolonged air travel: Coach class thrombosis","volume":"14","author":"Arfvidsson","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"key":"R4-14-20240205","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/qjmed\/90.6.375","article-title":"Inherited thrombophilias","volume":"90","author":"Laffan","year":"1997","journal-title":"Q J Med"},{"key":"R5-14-20240205","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/pgmj.72.844.87","article-title":"Guidelines for the management of thrombophilia","volume":"72","author":"Cavenagh","year":"1996","journal-title":"Postgrad Med J"},{"key":"R6-14-20240205","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2298\/MPNS0508368O","article-title":"Thrombophilia and thrombosis","volume":"58","author":"Obradovi\u03b6","year":"2005","journal-title":"Med Pregl"},{"key":"R7-14-20240205","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0733-8627(05)70221-2","article-title":"Epidemiology of venous thromboembolic disease","volume":"19","author":"Kim","year":"2001","journal-title":"Emer Med Clin North Am"},{"key":"R8-14-20240205","doi-asserted-by":"crossref","first-page":"531S","DOI":"10.1378\/chest.114.5_Supplement.531S","article-title":"Prevention of venous thromboembolism","volume":"114","author":"Clagett","year":"1998","journal-title":"Chest"},{"key":"R9-14-20240205","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/oxfordjournals.eurheartj.a015316","article-title":"Clinical epidemiology of venous thromboembolic disease: Results of a French multicentre registry","volume":"18","author":"Ferrari","year":"1997","journal-title":"Eur Heart J"},{"key":"R10-14-20240205","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0889-8545(05)70222-9","article-title":"Venous thromboembolism and pregnancy","volume":"28","author":"Andres","year":"2001","journal-title":"Obstet Gynecol Clin North Am"},{"key":"R11-14-20240205","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bmj.312.7023.83","article-title":"Third generation oral contraceptives and risk of venous thromboembolic disorders: An international case control study","volume":"312","author":"Spitzer","year":"1996","journal-title":"BMJ"},{"key":"R12-14-20240205","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(94)90286-0","article-title":"Increased risk of venous thrombosis in oral contraceptive users who are carriers of factor V Leiden mutation","volume":"344","author":"Vandenbroucke","year":"1994","journal-title":"Lancet"},{"key":"R13-14-20240205","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1182\/blood.V98.5.1614","article-title":"Increased risk of deep vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy","volume":"98","author":"Zangari","year":"2001","journal-title":"Blood"},{"key":"R17-14-20240205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-125-1-199607010-00001","article-title":"The long term clinical course of acute deep vein thrombosis","volume":"125","author":"Prandoni","year":"1996","journal-title":"Ann Intern Med"},{"key":"R18-14-20240205","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/archinte.160.6.761","article-title":"Predictors of recurrence after deep vein thrombosis and pulmonary embolism: A population-based cohort study","volume":"160","author":"Heit","year":"2000","journal-title":"Arch Intern Med"},{"key":"R19-14-20240205","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0889-8588(05)70138-6","article-title":"Hypercoagulable states","volume":"14","author":"Whiteman","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"key":"R21-14-20240205","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1182\/blood.V87.9.3531.bloodjournal8793531","article-title":"Inherited thrombophilia: Pathogenesis, clinical syndromes and management","volume":"87","author":"De Stefano","year":"1996","journal-title":"Blood"},{"key":"R22-14-20240205","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0889-8588(05)70047-2","article-title":"Laboratory evaluation of hypercoagulable states","volume":"12","author":"Van Cott","year":"1998","journal-title":"Hematol Oncol Clin North Am"},{"key":"R23-14-20240205","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1055\/s-0038-1648870","article-title":"Clinical manifestations and management of inherited thrombophilia: Retrospective analysis and follow up after diagnosis of 238 patients with congenital deficiency of antithrombin III, protein C and protein S","volume":"72","author":"De Stefano","year":"1994","journal-title":"Thromb Hemost"},{"key":"R26-14-20240205","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1056\/NEJM200104193441607","article-title":"Genetic susceptibility to venous thrombosis","volume":"344","author":"Seligsohn","year":"2001","journal-title":"N Engl J Med"},{"key":"R27-14-20240205","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ajh.2830360405","article-title":"Incidence and clinical characteristics of hereditary disorders associated with venous thrombosis","volume":"36","author":"Tabernero","year":"1991","journal-title":"Am J Hematol"},{"key":"R28-14-20240205","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1001\/archinte.1997.00440400077009","article-title":"Recurrence of venous thromboembolism in patients with familial thrombophilia","volume":"157","author":"van den Belt","year":"1997","journal-title":"Arch Intern Med"},{"key":"R29-14-20240205","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1055\/s-0038-1650638","article-title":"Inherited thrombophilia","volume":"76","author":"Lane","year":"1996","journal-title":"Thromb Haemost"},{"key":"R30-14-20240205","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1182\/blood.V85.10.2756.bloodjournal85102756","article-title":"Protein C deficiency in a controlled series of unselected outpatients: An infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study)","volume":"85","author":"Koster","year":"1995","journal-title":"Blood"},{"key":"R31-14-20240205","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/00001721-199212000-00008","article-title":"Congenital thrombophilia among patients with venous thromboembolism","volume":"3","author":"Melissari","year":"1992","journal-title":"Blood Coag Fibrinolysis"},{"key":"R32-14-20240205","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1159\/000045840","article-title":"Low molecular weight heparin in hemodialysis patients with a bleeding tendency","volume":"86","author":"Leu","year":"2000","journal-title":"Nephron"},{"key":"R33-14-20240205","first-page":"217","article-title":"Resistance to activated protein C as a risk factor for thrombosis: Molecular mechanisms, laboratory investigations and management","volume":"34","author":"Dahlback","year":"1997","journal-title":"Semin Hematol"},{"key":"R34-14-20240205","doi-asserted-by":"crossref","first-page":"643","DOI":"10.7326\/0003-4819-130-8-199904200-00004","article-title":"Activated protein C resistance and factor V Leiden are independent risk factors for venous thromboembolism","volume":"130","author":"Rodeghiero","year":"1999","journal-title":"Ann Intern Med"},{"key":"R35-14-20240205","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1182\/blood.V91.4.1135","article-title":"A novel mutation of Arg 306 of factor V gene in Hong Kong Chinese","volume":"91","author":"Chan","year":"1998","journal-title":"Blood"},{"key":"R36-14-20240205","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1182\/blood.V91.4.1140","article-title":"Factor V Cambridge: A new mutation (Arg306\u00e0Thr) associated with resistance to activated protein C","volume":"91","author":"Williamson","year":"1998","journal-title":"Blood"},{"key":"R37-14-20240205","first-page":"167","article-title":"Introduction: Hypercoagulable states","volume":"34","author":"Bertina","year":"1997","journal-title":"Semin Hematol"},{"key":"R38-14-20240205","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(05)80081-9","article-title":"Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study","volume":"342","author":"Koster","year":"1993","journal-title":"Lancet"},{"key":"R39-14-20240205","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1172\/JCI117623","article-title":"Identification of the same factor V gene mutation in 47 out of 50 thrombosis prone families with inherited resistance to activated protein C","volume":"94","author":"Z\u03c6ller","year":"1994","journal-title":"J Clin Invest"},{"key":"R40-14-20240205","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1056\/NEJM199504063321403","article-title":"Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke and venous thrombosis is apparently healthy men","volume":"332","author":"Ridker","year":"1995","journal-title":"N Engl J Med"},{"key":"R41-14-20240205","first-page":"526","article-title":"Budd-Chiari syndrome and factor V Leiden mutation","volume":"345","author":"Mahmoud","year":"1995","journal-title":"Lancet"},{"key":"R42-14-20240205","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1161\/01.STR.27.10.1721","article-title":"Marnet L, Mas JL. Factor V Leiden mutation in cerebral venous thrombosis","volume":"27","author":"Zuber","year":"1996","journal-title":"Stroke"},{"key":"R44-14-20240205","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0140-6736(95)90008-X","article-title":"Is hyperhomocysteinemia a risk factor for recurrent venous thrombosis?","volume":"345","author":"den Heijer","year":"1995","journal-title":"Lancet"},{"key":"R45-14-20240205","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0049-3848(93)90160-P","article-title":"Homocystienemia: Association of a metabolic disorder with vascular disease and thrombosis","volume":"71","author":"Rees","year":"1993","journal-title":"Thromb Res"},{"key":"R46-14-20240205","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1161\/01.ATV.14.7.1080","article-title":"High prevalence of hyperhomocysteinemia in patients with juvenile venous thrombosis","volume":"14","author":"Falcon","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"R48-14-20240205","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0889-8588(05)70049-6","article-title":"Update on genetic risk factors for thrombosis and atherosclerotic vascular disease","volume":"12","author":"Neufeld","year":"1998","journal-title":"Haematol Oncol Clin North Am"},{"key":"R49-14-20240205","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1055\/s-0038-1657602","article-title":"The Leiden thrombophilia study (LETS)","volume":"78","author":"van der Meer","year":"1997","journal-title":"Thromb Hemost"},{"key":"R50-14-20240205","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0140-6736(95)90166-3","article-title":"Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep vein thrombosis","volume":"345","author":"Koster","year":"1995","journal-title":"Lancet"},{"key":"R51-14-20240205","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJM200008173430702","article-title":"High plasma levels of factor VIII and the risk of recurrent venous thromboembolism","volume":"343","author":"Kyrle","year":"2000","journal-title":"N Engl J Med"},{"key":"R52-14-20240205","first-page":"78","article-title":"Antiphospholipid antibodies and thrombosis: A consequence, coincidence or cause?","volume":"117","author":"Triplett","year":"1993","journal-title":"Arch Pathol Lab Med"},{"key":"R53-14-20240205","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1182\/blood.V86.10.3685.bloodjournal86103685","article-title":"Antiphospholipid antibodies and venous thromboembolism","volume":"86","author":"Ginsberg","year":"1995","journal-title":"Blood"},{"key":"R54-14-20240205","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0889-8588(05)70048-4","article-title":"Lupus anticoagulants and antiphospholipid antibodies","volume":"12","author":"Thiagarajan","year":"1998","journal-title":"Hematol Oncol Clin North Am"},{"key":"R55-14-20240205","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1182\/blood.V84.4.1031.1031","article-title":"Activated protein C resistance as an additional risk factor for thrombosis in protein C deficient families","volume":"84","author":"Koeleman","year":"1994","journal-title":"Blood"},{"key":"R56-14-20240205","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/107602960100700214","article-title":"Venous thromboembolism in young patients from western India: A study","volume":"7","author":"Ghosh","year":"2001","journal-title":"Clin Appl Thromb Hemost"}],"container-title":["Journal of Postgraduate Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00005257-200955010-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:52:31Z","timestamp":1786647151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005257-200955010-00014"}},"subtitle":["The intricacies"],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.4103\/0022-3859.48442","relation":{},"ISSN":["0022-3859"],"issn-type":[{"value":"0022-3859","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}